This compound is a synthetic peptide similar to human angiotensin III, provided as an acetate salt and used as an active pharmaceutical ingredient in formulations for managing low blood pressure associated with septic shock. Its structure includes multiple amide bonds, aromatic rings, and a heterocyclic group, reflecting its peptide nature.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 100900-06-9
ANGIOTENSIN II
vasoconstrictor active pharmaceutical ingredient
Angiotensin I human acetate salt hydrate
research compound for renin-angiotensin system
ANGIOTENSIN I
active pharmaceutical ingredient
Val(5)-angiotensin II
research peptide hormone
Daklatasvir
active pharmaceutical ingredient
Daclatasvir dihydrochloride
active pharmaceutical ingredient
Vistusertib
active pharmaceutical ingredient
Levofloksasin
active pharmaceutical ingredient
acetic acid;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid
DNYUGSNUNZSLJA-BZDVFTEGSA-N
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)N.CC(=O)O